Millennium Management’s Catalyst Pharmaceutical CPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $19M | Sell |
766,991
-226,656
| -23% | -$5.4M | 0.01% | 1600 |
|
|
2025
Q4 | $23.2M | Sell |
993,647
-185,535
| -16% | -$4.13M | 0.01% | 1429 |
|
|
2025
Q3 | $23.2M | Buy |
1,179,182
+749,052
| +174% | +$15.4M | 0.01% | 1512 |
|
|
2025
Q2 | $9.33M | Buy |
430,130
+126,597
| +42% | +$2.99M | ﹤0.01% | 2335 |
|
|
2025
Q1 | $7.36M | Sell |
303,533
-217,245
| -42% | -$4.89M | ﹤0.01% | 2486 |
|
|
2024
Q4 | $10.9M | Sell |
520,778
-38,989
| -7% | -$838K | 0.01% | 2109 |
|
|
2024
Q3 | $11.1M | Buy |
559,767
+429,954
| +331% | +$7.97M | 0.01% | 2098 |
|
|
2024
Q2 | $2.01M | Buy |
129,813
+25,277
| +24% | +$394K | ﹤0.01% | 3537 |
|
|
2024
Q1 | $1.67M | Sell |
104,536
-74,185
| -42% | -$1.12M | ﹤0.01% | 3890 |
|
|
2023
Q4 | $3M | Sell |
178,721
-161,550
| -47% | -$2.21M | ﹤0.01% | 3249 |
|
|
2023
Q3 | $3.98M | Buy |
340,271
+25,210
| +8% | +$337K | ﹤0.01% | 2918 |
|
|
2023
Q2 | $4.23M | Sell |
315,061
-1,040,034
| -77% | -$15M | ﹤0.01% | 2807 |
|
|
2023
Q1 | $22.5M | Sell |
1,355,095
-958,571
| -41% | -$15.8M | 0.01% | 1256 |
|
|
2022
Q4 | $43M | Buy |
2,313,666
+873,308
| +61% | +$13.4M | 0.02% | 847 |
|
|
2022
Q3 | $18.5M | Sell |
1,440,358
-1,283,537
| -47% | -$15.2M | 0.01% | 1428 |
|
|
2022
Q2 | $19.1M | Buy |
2,723,895
+1,560,086
| +134% | +$11.4M | 0.01% | 1361 |
|
|
2022
Q1 | $9.65M | Buy |
1,163,809
+932,377
| +403% | +$6.59M | 0.01% | 2208 |
|
|
2021
Q4 | $1.57M | Buy |
231,432
+177,246
| +327% | +$1.17M | ﹤0.01% | 3991 |
|
|
2021
Q3 | $287K | Sell |
54,186
-245,187
| -82% | -$1.34M | ﹤0.01% | 5850 |
|
|
2021
Q2 | $1.72M | Sell |
299,373
-312,637
| -51% | -$1.61M | ﹤0.01% | 4139 |
|
|
2021
Q1 | $2.82M | Buy |
612,010
+174,924
| +40% | +$695K | ﹤0.01% | 3197 |
|
|
2020
Q4 | $1.46M | Buy |
437,086
+406,817
| +1,344% | +$1.37M | ﹤0.01% | 3471 |
|
|
2020
Q3 | $90 | Sell |
30,269
-234,784
| -89% | -$918K | ﹤0.01% | 4240 |
|
|
2020
Q2 | $1.23M | Sell |
265,053
-567,948
| -68% | -$2.55M | ﹤0.01% | 2873 |
|
|
2020
Q1 | $3.21M | Buy |
833,001
+801,306
| +2,528% | +$3.29M | 0.01% | 1680 |
|
|
2019
Q4 | $119K | Sell |
31,695
-44,151
| -58% | -$206K | ﹤0.01% | 3998 |
|
|
2019
Q3 | $402K | Buy |
+75,846
| New | +$404K | ﹤0.01% | 3395 |
|
|
2018
Q4 | – | Sell |
-134,019
| Closed | -$507K | – | 3803 |
|
|
2018
Q3 | $507K | Sell |
134,019
-1,476,157
| -92% | -$4.62M | ﹤0.01% | 3252 |
|
|
2018
Q2 | $5.02M | Buy |
1,610,176
+227,918
| +16% | +$691K | 0.01% | 1816 |
|
|
2018
Q1 | $3.3M | Sell |
1,382,258
-684,622
| -33% | -$2.28M | ﹤0.01% | 2038 |
|
|
2017
Q4 | $8.08M | Buy |
+2,066,880
| New | +$6.83M | 0.01% | 1468 |
|
|
2017
Q3 | – | Sell |
-22,564
| Closed | -$62K | – | 3546 |
|
|
2017
Q2 | $62K | Sell |
22,564
-37,503
| -62% | -$78.3K | ﹤0.01% | 3349 |
|
|
2017
Q1 | $117K | Sell |
60,067
-259,801
| -81% | -$331K | ﹤0.01% | 3304 |
|
|
2016
Q4 | $336K | Sell |
319,868
-158,296
| -33% | -$181K | ﹤0.01% | 2843 |
|
|
2016
Q3 | $521K | Sell |
478,164
-169,581
| -26% | -$153K | ﹤0.01% | 2586 |
|
|
2016
Q2 | $460K | Buy |
647,745
+612,697
| +1,748% | +$494K | ﹤0.01% | 2525 |
|
|
2016
Q1 | $41K | Sell |
35,048
-212,781
| -86% | -$330K | ﹤0.01% | 3162 |
|
|
2015
Q4 | $607K | Buy |
247,829
+234,127
| +1,709% | +$671K | ﹤0.01% | 2550 |
|
|
2015
Q3 | $41K | Sell |
13,702
-3,998
| -23% | -$17.3K | ﹤0.01% | 3358 |
|
|
2015
Q2 | $73K | Sell |
17,700
-64,672
| -79% | -$258K | ﹤0.01% | 3204 |
|
|
2015
Q1 | $357K | Buy |
+82,372
| New | +$297K | ﹤0.01% | 2939 |
|
|
2014
Q4 | – | Sell |
-82,770
| Closed | -$275K | – | 3961 |
|
|
2014
Q3 | $275K | Buy |
+82,770
| New | +$216K | ﹤0.01% | 3149 |
|
Other funds holding CPRX
VCM
DM
VPM
Millennium Management's CPRX Position: Q1 2026 in Review
Millennium Management reduced its Catalyst Pharmaceutical (CPRX) stake by 23% in Q1 2026, selling an estimated $5.4M and leaving 766,991 shares worth $19M. The position accounts for 0.01% of the portfolio, ranked #1600.
Millennium Management first reported a position in CPRX in Q3 2014 and has held it in 42 quarters since. The position peaked at $43M in Q4 2022. 380 funds tracked by Wall St. Rank hold CPRX as of Q1 2026.
- Millennium Management held 766,991 shares of Catalyst Pharmaceutical worth $19M as of Q1 2026.
- Millennium Management sold 226,656 Catalyst Pharmaceutical shares in Q1 2026, an estimated $5.4M.
- Catalyst Pharmaceutical made up 0.01% of Millennium Management's portfolio in Q1 2026, its #1600 holding.
- Millennium Management first reported a position in Catalyst Pharmaceutical in Q3 2014 and has held it in 42 quarters since.
- Millennium Management's Catalyst Pharmaceutical position peaked at $43M in Q4 2022.
- 380 funds tracked by Wall St. Rank held Catalyst Pharmaceutical as of Q1 2026.
Based on Millennium Management's 13F filing for Q1 2026, filed 15 May 2026.